Recently, compromise texts were agreed by the European Commission, Council and Parliament on new legislation on Medical Devices (MD) and on In Vitro Diagnostic (IVD) Medical Devices (MD).  A key issue that remains to be dealt with is the reimbursement of diagnostic tests that are necessary to personalised medicines.

What might this mean for patients, and where is additional coordination between regulators, industry, patients and payers necessary?
Speakers:

salvatore-scalzo littlesq Bettina_100x100 littlesq  
Salvatore Scalzo
Policy and Legal Officer,
Unit GROW D.4,
European Commission
  Bettina Ryll
Founder,
Melanoma Patient Network Europe
   
littlesq   littlesq   littlesq

To download the slides, please click here.

Watch here the recording of the webinar.


 

footer2

07 November 2016 in Highlights